BIS logo

ProShares UltraShort Nasdaq Biotechnology (BIS)

$8.81

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on BIS

AUM

$2476456

P/E ratio

--

Dividend yield

4.9652%

Expense ratio

0.95%

Beta

-1.227088

Price on BIS

Previous close

$8.33

Today's open

$8.52

Day's range

$8.52 - $8.83

52 week range

$7.95 - $20.81

Profile about BIS

show more

Headquarters

US

Exchange

NASDAQ Global Market

Issue type

Exchange-Traded Fund

BIS industries and sectors

Alternatives

Trading Tools

News on BIS

Medical Technology Stocks: Innovation Endures As Valuations Reset

Investors are questioning the staying power of medical technology (medtech) stocks, which have fallen from grace since the COVID-19 pandemic. The starting point is to distinguish between medtech and other healthcare industries.

news source

Seeking Alpha • May 2, 2026

news preview

Global PMI: Tracking The Sectors Hit Hardest By The Middle East War

Survey data underscored how the war in the Middle East has already had a material impact on economic growth around the world. Drilling down deeper, the data showed weaker growth trends were recorded across all major industries globally.

news source

Seeking Alpha • Apr 12, 2026

news preview

Investing In Health Stocks - How Policy Clarity Is Opening Doors

The healthcare sector has experienced one of its most significant de-ratings in 35 years, with valuations now at a 30% discount to the broader market. Healthcare trades at historical valuation discounts across multiple metrics.

news source

Seeking Alpha • Nov 11, 2025

news preview

Healthcare Sector Checkup As U.S. Looks To Change Regulations

Outlook for pharma sector as Trump pushes for regulatory changes. The impact of tariffs on drugmakers.

news source

Seeking Alpha • May 30, 2025

news preview

Top Performing Leveraged/Inverse ETFs: 05/11/2025

Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.

news source

ETF Trends • May 14, 2025

news preview

Seeking Stocks With Vitality In The Volatile Healthcare Sector

Investors cooled to the healthcare sector in 2024, which dramatically trailed global and US equity markets for the year. any investors are now asking: how will the policy changes under a new US administration affect healthcare companies?

news source

Seeking Alpha • Feb 25, 2025

news preview

Top Performing Leveraged/Inverse ETFs: 11/17/2024

Top Performing Levered/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.

news source

ETF Trends • Nov 19, 2024

news preview

3 ETFs in “Oversold” Territory to Start the Week

Technical analysis can tell investors a lot about both stocks and ETFs, including when some might have been overbought, or even oversold.

news source

ETF Trends • Dec 5, 2022

news preview

2 ETFs to Watch for Outsized Volume on Internet & Inverse Leveraged Biotech

Inverse leveraged biotech ETF and internet ETF traded with an outsized volume on Friday.

news source

Zacks Investment Research • Oct 10, 2022

news preview

Purchase Levels Of 31 Short ETFs Signal Bear Market Bottom (Technical Analysis)

We are bearish on all American bear market ETFs. Measuring the purchase levels of short ETFs replaces the old, odd lot and total short selling indicators so popular in the 1960s, 70s and 80s.

news source

Seeking Alpha • Aug 8, 2022

news preview

¹ Disclosures

Get started with M1

Invest in ProShares UltraShort Nasdaq Biotechnology

Open an M1 investment account to buy and sell ProShares UltraShort Nasdaq Biotechnology commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in BIS on M1